165 related articles for article (PubMed ID: 31995010)
1. Binding Insight of Anti-HIV Phytocompounds with Prime Targets of HIV: A Molecular Dynamics Simulation Analysis.
Vora J; Athar M; Sinha S; Jha PC; Shrivastava N
Curr HIV Res; 2020; 18(2):132-141. PubMed ID: 31995010
[TBL] [Abstract][Full Text] [Related]
2. New anti-HIV agents and targets.
De Clercq E
Med Res Rev; 2002 Nov; 22(6):531-65. PubMed ID: 12369088
[TBL] [Abstract][Full Text] [Related]
3. Dimerization inhibitors of HIV-1 reverse transcriptase, protease and integrase: a single mode of inhibition for the three HIV enzymes?
Camarasa MJ; Velázquez S; San-Félix A; Pérez-Pérez MJ; Gago F
Antiviral Res; 2006 Sep; 71(2-3):260-7. PubMed ID: 16872687
[TBL] [Abstract][Full Text] [Related]
4. Molecular Docking and Molecular Dynamics Simulation Based Approach to Explore the Dual Inhibitor Against HIV-1 Reverse Transcriptase and Integrase.
Chander S; Pandey RK; Penta A; Choudhary BS; Sharma M; Malik R; Prajapati VK; Murugesan S
Comb Chem High Throughput Screen; 2017; 20(8):734-746. PubMed ID: 28641512
[TBL] [Abstract][Full Text] [Related]
5. New developments in anti-HIV chemotherapy.
De Clercq E
Biochim Biophys Acta; 2002 Jul; 1587(2-3):258-75. PubMed ID: 12084468
[TBL] [Abstract][Full Text] [Related]
6. Active site binding modes of dimeric phloroglucinols for HIV-1 reverse transcriptase, protease and integrase.
Gupta P; Kumar R; Garg P; Singh IP
Bioorg Med Chem Lett; 2010 Aug; 20(15):4427-31. PubMed ID: 20594846
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic analysis of the sensitivity of HIV-1 to inhibitors of the reverse transcriptase, protease, and integrase using a self-inactivating virus vector system.
Jármy G; Heinkelein M; Weissbrich B; Jassoy C; Rethwilm A
J Med Virol; 2001 Jul; 64(3):223-31. PubMed ID: 11424108
[TBL] [Abstract][Full Text] [Related]
8. Evolution of HIV-1 reverse transcriptase and integrase dual inhibitors: Recent advances and developments.
Gill MSA; Hassan SS; Ahemad N
Eur J Med Chem; 2019 Oct; 179():423-448. PubMed ID: 31265935
[TBL] [Abstract][Full Text] [Related]
9. [Advances in novel anti-HIV-1 drugs and drug candidates: 2005-2008].
Zheng PR; Xue H; Xiao ZY; Liu G
Yao Xue Xue Bao; 2010 Feb; 45(2):154-64. PubMed ID: 21351426
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 integrase and RNase H activities as therapeutic targets.
Andréola ML; De Soultrait VR; Fournier M; Parissi V; Desjobert C; Litvak S
Expert Opin Ther Targets; 2002 Aug; 6(4):433-46. PubMed ID: 12223059
[TBL] [Abstract][Full Text] [Related]
11. Active site binding modes of curcumin in HIV-1 protease and integrase.
Vajragupta O; Boonchoong P; Morris GM; Olson AJ
Bioorg Med Chem Lett; 2005 Jul; 15(14):3364-8. PubMed ID: 15950462
[TBL] [Abstract][Full Text] [Related]
12. Dual inhibitor design for HIV-1 reverse transcriptase and integrase enzymes: a molecular docking study.
Ercan S; Şenyiğit B; Şenses Y
J Biomol Struct Dyn; 2020 Feb; 38(2):573-580. PubMed ID: 31787027
[TBL] [Abstract][Full Text] [Related]
13. Molecular docking, QSAR and ADMET based mining of natural compounds against prime targets of HIV.
Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
J Biomol Struct Dyn; 2019 Jan; 37(1):131-146. PubMed ID: 29268664
[TBL] [Abstract][Full Text] [Related]
14. The plant ribosome inactivating proteins luffin and saporin are potent inhibitors of HIV-1 integrase.
Au TK; Collins RA; Lam TL; Ng TB; Fong WP; Wan DC
FEBS Lett; 2000 Apr; 471(2-3):169-72. PubMed ID: 10767416
[TBL] [Abstract][Full Text] [Related]
15. Graph theory concepts in the rationales of anti HIV-1 compounds.
Debnath U; Katti SB; Prabhakar YS
Curr Comput Aided Drug Des; 2013 Dec; 9(4):472-81. PubMed ID: 24138418
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of 3-hydroxy-3-phenylpropanoate ester–AZT conjugates as potential dual-action HIV-1 Integrase and Reverse Transcriptase inhibitors.
Manyeruke MH; Olomola TO; Majumder S; Abrahams S; Isaacs M; Mautsa N; Mosebi S; Mnkandhla D; Hewer R; Hoppe HC; Klein R; Kaye PT
Bioorg Med Chem; 2015 Dec; 23(24):7521-8. PubMed ID: 26775541
[TBL] [Abstract][Full Text] [Related]
17. Combinations of reverse transcriptase, protease, and integrase inhibitors can be synergistic in vitro against drug-sensitive and RT inhibitor-resistant molecular clones of HIV-1.
Beale KK; Robinson WE
Antiviral Res; 2000 Jun; 46(3):223-32. PubMed ID: 10867160
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory activity on HIV-1 reverse transcriptase and integrase of a carmalol derivative from a brown Alga, Ishige okamurae.
Ahn MJ; Yoon KD; Kim CY; Kim JH; Shin CG; Kim J
Phytother Res; 2006 Aug; 20(8):711-3. PubMed ID: 16775811
[TBL] [Abstract][Full Text] [Related]
19. Anti-HIV/SIV activity of icariin and its metabolite anhydroicaritin mainly involve reverse transcriptase.
Xie Y; Xie L; Chen A; Wu S; Mo Y; Guo X; Zeng C; Huang X; He J
Eur J Pharmacol; 2020 Oct; 884():173327. PubMed ID: 32726656
[TBL] [Abstract][Full Text] [Related]
20. Peptides as new inhibitors of HIV-1 reverse transcriptase and integrase.
de Soultrait VR; Desjobert C; Tarrago-Litvak L
Curr Med Chem; 2003 Sep; 10(18):1765-78. PubMed ID: 12871103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
